Genetic Features and Clinical Heterogeneity of Leber Hereditary Optic Neuropathy in Adolescent and Adult Patients: A Case Series on Arab Patients

Esraa Basalem,1 Nooran Badeeb1,2 1Department of Ophthalmology, King Fahad Armed Forces Hospital, Ministry of Defense Health Services, Jeddah, Saudi Arabia; 2Department of Surgery, Ophthalmology Division, College of Medicine, University of Jeddah, Jeddah, Saudi ArabiaCorrespondence: Nooran Badeeb, Department of Surgery, Ophthalmology Division, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia, Tel +966555517944, Email [email protected]: Leber hereditary optic neuropathy (LHON) is a rare disorder characterized by painless progressive visual loss. LHON is caused by maternally inherited mitochondrial DNA (mtDNA) point mutations, impairing the electron transport chain and oxidative phosphorylation. Environmental and nuclear factors may further influence disease manifestation. This case series describes the clinical characteristics, mutation profiles, and visual outcomes in patients from Saudi Arabia and Yemen, regions where reported data remain scarce. Patients were diagnosed with LHON based on characteristic clinical features confirmed through genetic testing. The series highlights both adolescent-and adult-disease onset, with most patients carrying the m.11778G>A mutation, consistent with global prevalence patterns. Distinct modifiable risk factors were identified in several cases. Treatment with Idebenone (two out of two patients) was associated with visual improvement and favorable outcomes, while patients treated with coenzyme Q10 reported subjective visual improvement that was not detected through visual assessments. These findings contribute to the limited data on LHON in the Arabian Peninsula underscoring the importance of early genetic testing and treatment initiation. However, the small sample size, non-uniform participant visit schedules, and variable follow-up period limit the generalizability of the findings. Increased regional awareness and reporting, as well as mitigating financial obstacles, are essential to improve diagnostic timing and optimize outcomes in this rare but impactful disorder.Keywords: LHON, Idebenone, m.11778G>A, Arabian Peninsula

Authors

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2026-04-30
Primary Topic
Mitochondrial Function and Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genetic Features and Clinical Heterogeneity of Leber Hereditary Optic Neuropathy in Adolescent and Adult Patients: A Case Series on Arab Patients

Esraa Basalem, Nooran Badeeb
Dove Medical Press (Taylor and Francis Group)
Mitochondrial Function and Pathology
article

Genetic Features and Clinical Heterogeneity of Leber Hereditary Optic Neuropathy in Adolescent and Adult Patients: A Case Series on Arab Patients

Esraa Basalem, Nooran Badeeb
article en

Abstract

Esraa Basalem,1 Nooran Badeeb1,2 1Department of Ophthalmology, King Fahad Armed Forces Hospital, Ministry of Defense Health Services, Jeddah, Saudi Arabia; 2Department of Surgery, Ophthalmology Division, College of Medicine, University of Jeddah, Jeddah, Saudi ArabiaCorrespondence: Nooran Badeeb, Department of Surgery, Ophthalmology Division, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia, Tel +966555517944, Email [email protected]: Leber hereditary optic neuropathy (LHON) is a rare disorder characterized by painless progressive visual loss. LHON is caused by maternally inherited mitochondrial DNA (mtDNA) point mutations, impairing the electron transport chain and oxidative phosphorylation. Environmental and nuclear factors may further influence disease manifestation. This case series describes the clinical characteristics, mutation profiles, and visual outcomes in patients from Saudi Arabia and Yemen, regions where reported data remain scarce. Patients were diagnosed with LHON based on characteristic clinical features confirmed through genetic testing. The series highlights both adolescent-and adult-disease onset, with most patients carrying the m.11778G>A mutation, consistent with global prevalence patterns. Distinct modifiable risk factors were identified in several cases. Treatment with Idebenone (two out of two patients) was associated with visual improvement and favorable outcomes, while patients treated with coenzyme Q10 reported subjective visual improvement that was not detected through visual assessments. These findings contribute to the limited data on LHON in the Arabian Peninsula underscoring the importance of early genetic testing and treatment initiation. However, the small sample size, non-uniform participant visit schedules, and variable follow-up period limit the generalizability of the findings. Increased regional awareness and reporting, as well as mitigating financial obstacles, are essential to improve diagnostic timing and optimize outcomes in this rare but impactful disorder.Keywords: LHON, Idebenone, m.11778G>A, Arabian Peninsula

Dove Medical Press (Taylor and Francis Group)
Openalex Percentile: Top 7%
Mitochondrial Function and Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.